Revolution Medicines, the fast-growing developer racing toward its first commercial cancer drug, is in advanced talks for roughly 700,000 square feet at Pacific...
ByThe RegistryAugust 21, 2026Life sciences retreat drives 566,728 SQFT of losses in R&D sector as AI funding surges to $1.23 billion; industrial sees $71.1 million in...
ByThe RegistryNovember 3, 2025The San Francisco Peninsula R&D market continued to experience challenges in the fourth quarter of 2024, with net absorption recording negative 343,548 square...
ByThe RegistryFebruary 11, 2025
Signup for news and special announcements!
You have successfully joined our subscriber list.